Mouse Grin3a/6430537F04/A830097C19Rik ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_001033351.2)

Cat. No.: pGMAAV001292
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Grin3a/6430537F04/A830097C19Rik Adeno-associated virus expression plasmid (ITR-vector) for Grin3a AAV packaging, Grin3a AAV production.The purified Mouse Grin3a/6430537F04/A830097C19Rik AAV particle serves as an invaluable asset for in-depth in vivo Grin3a studies, mechanism of action (MOA) research, and the evolution of Grin3a-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001292
Gene Name Grin3a
Accession Number NM_001033351.2
Gene ID 242443
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 3348 bp
Gene Alias 6430537F04,A830097C19Rik,GluN3A,mKIAA1973,NMDAR-L,NMDAR3A,NR3A
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter hSyn
Resistance Amplicin
ORF Nucleotide Sequence ATGAGGAGACTGAGTTTGTGGTGGCTGCTGAGCAGGGTCTGTCTGTTGCTGCCTCCGCCCTGTGCACTGGTGCTGGCCGGGGTGCCCAGCTCCTCCTCGCACCCGCAACCCTGCCAGATCCTCAAGCGCATCGGACACGCGGTGAGGGTGGGCGCGGTGCACTTGCAACCCTGGACCACGGCCCCACGCGCAGCCAGTCGCGCTCAGGACGGCGGCAGGGCGGGTGCCCAGAGGGATGAGCCAGAGTCGGGGACGTGGCGGCCACCGGCGCCCTCGCAAGGCGCACGTTGGTTGGGGAGCGCCCTGCATGGCCGGGGTCCACCCGGCTCCCGCAAGCTCGGGGAGGGCGCCGGGACCGAGACCCTGTGGCCGCGGGATGCCCTACTGTTCGCTGTGGAAAACCTGAACCGTGTGGAAGGGCTCCTTCCCTACAACCTGTCTTTGGAAGTAGTGATGGCCATCGAGGCGGGCCTGGGCGACCTGCCACTTATGCCTTTCTCTTCCCCAAGCTCACCGTGGAGCAGTGACCCTTTCTCCTTTCTGCAGAGCGTGTGCCACACCGTAGTGGTACAAGGGGTTTCAGCGCTGCTGGCCTTCCCCCAGAGCCAGGGCGAAATGATGGAGCTGGACTTGGTCAGTTCTGTCCTGCACATCCCAGTGCTCAGCATAGTGCGCCACGAGTTTCCGCGGGAGAGTCAGAATCCCCTGCACCTACAGCTGAGTTTAGAAAATTCACTAAGTTCTGATGCTGATGTCACTGTCTCAATCCTGACCATGAACAACTGGTACAATTTTAGCTTGTTGCTATGCCAGGAAGACTGGAATATCACCGACTTCCTACTCCTTACAGAGAATAACTCCAAGTTCCACCTCGAGTCTATCATCAACATCACTGCTAACCTGTCCTCCACAAAGGACCTTCTAAGTTTCCTGCAGGTCCAGCTGGAAAACATTAGGAACAGCACACCCACAATGGTGATGTTTGGCTGTGACATGGGGAGCATCCGGCAGATATTTGAAATGTCCACACAGTTTGGGCTATCACCTCCTGATCTTCACTGGGTTTTAGGAGACTCACAGAATGTGGAGGAGCTGAGGACAGAAGGCCTGCCCTTAGGGCTCATTGCTCATGGAAAAACCACACAGTCTGTCTTTGAGTACTATGTTCAGGATGCCATGGAGTTGGTTGCAAGAGCTGTAGCCACAGCCACCATGATCCAGCCAGAACTTGCTCTCCTTCCCAGCACAATGAACTGCATGGATGTGAAAACCACAAATCTCACTTCTGGACAATATTTATCAAGGTTTTTAGCCAACACCACTTTCAGAGGTCTCAGTGGTTCCATCAAAGTAAAGGGATCCACCATCGTCAGCTCAGAAAACAACTTTTTCATCTGGAACTTGCAGTATGACCCTATGGGAAAGCCAATGTGGACTCGCCTGGGTAGCTGGCAAGGGGGAAGGATTGTCATGGACTCGGGAATATGGCCAGAGCAGGCCCAGAGGCACAAAACCCACTTCCATCACCCAAACAAGTTACACTTGAGAGTGGTGACACTGATTGAACATCCATTTGTTTTCACGAGAGAAGTAGATGATGAAGGCTTATGCCCTGCTGGACAACTCTGTCTAGACCCTATGACTAATGACTCTTCCATACTGGATAGCCTGTTTAGCAGCCTACATAGCAGTAATGATACAGTGCCAATCAAGTTCAAGAAGTGCTGCTATGGGTATTGCATTGATCTACTGGAACAGTTAGCAGAAGACATGAACTTTGACTTTGACCTCTATATTGTAGGGGATGGAAAGTATGGAGCTTGGAAAAATGGTCACTGGACTGGGCTGGTTGGTGATCTCCTGAGTGGAACAGCCAACATGGCAGTCACTTCTTTCAGCATCAATACTGCAAGAAGCCAAGTGATAGATTTCACCAGCCCTTTCTTCTCAACCAGTTTGGGCATCTTAGTGAGGACTCGAGACACAGCAGCTCCCATTGGAGCCTTCATGTGGCCACTCCACTGGACCATGTGGCTGGGGATTTTCGTGGCTCTACATATCACTGCCATCTTCCTCACTCTGTATGAATGGAAGAGCCCCTTTGGTATGACTCCTAAAGGGAGGAACAGAAACAAAGTCTTCTCCTTCTCCTCAGCCTTGAATGTCTGCTATGCCCTTCTGTTTGGCAGAACAGCAGCCATCAAACCCCCTAAATGCTGGACTGGAAGATTTCTGATGAATCTTTGGGCCATTTTCTGTATGTTTTGCCTTTCTACATACACAGCGAACTTGGCTGCTGTCATGGTAGGTGAGAAGATCTATGAAGAACTTTCTGGAATCCATGACCCTAAGCTTCATCATCCTTCTCAAGGTTTTCGTTTTGGAACTGTCCGGGAAAGCAGTGCTGAGGACTATGTACGGCAGAGCTTCCCAGAGATGCATGAGTACATGAGAAGGTACAATGTACCAGCCACCCCTGATGGAGTGCAGTACCTGAAGAATGATCCAGAGAAACTAGATGCCTTCATCATGGACAAAGCCCTTCTGGATTATGAAGTGTCAATAGATGCTGACTGCAAGCTTCTGACCGTAGGAAAGCCATTTGCCATTGAAGGCTATGGCATTGGTCTCCCTCCCAACTCTCCGTTGACCTCTAACATATCTGAGCTCATCAGTCAGTACAAGTCTCATGGGTTTATGGATGTGCTTCATGACAAGTGGTACAAGGTGGTTCCCTGCGGAAAGAGAAGCTTTGCTGTCACTGAGACTTTGCAAATGGGCATCAAGCATTTCTCTGGACTCTTCGTGCTGCTGTGCATAGGATTCGGTCTCTCCATCCTGACAACCATTGGTGAACACATAGTGTACAGACTGCTGCTACCACGAATCAAAAACAAATCCAAGCTGCAGTACTGGCTGCACACCAGTCAGAGGTTTCACAGAGCATTAAACACATCATTTGTAGAAGAAAAGCAGCCATGTTCCAAGACAAAACGTGTGGAAAAGAGGTCCAACATGGGACCCCAGCAGCTCATGGTATGGAATACTTCCAATCTGAGTCACGACAACCAACGAAAATACATCTTTAATGATGAGGAAGGACAAAACCAGCTGGGTACCCAGACCCATCAGGACATCCCTCTCCCTCCAAGGAGAAGAGAGCTCCCTGCTTCACTGACCACCAATGGGAAAGCAGACTCCCTCAATGTAGCTCGGAACTCCGTGATGCAGGAACTCTCCGAGTTGGAGAAGCAGATCCAAGTGATCCGCCAGGAGCTGCAGTTGGCCGTAAGCAGGAAGACAGAGCTTGAGGAGTATCAAAGGACGAACCGGACTTGTGAATCCTAG
ORF Protein Sequence MRRLSLWWLLSRVCLLLPPPCALVLAGVPSSSSHPQPCQILKRIGHAVRVGAVHLQPWTTAPRAASRAQDGGRAGAQRDEPESGTWRPPAPSQGARWLGSALHGRGPPGSRKLGEGAGTETLWPRDALLFAVENLNRVEGLLPYNLSLEVVMAIEAGLGDLPLMPFSSPSSPWSSDPFSFLQSVCHTVVVQGVSALLAFPQSQGEMMELDLVSSVLHIPVLSIVRHEFPRESQNPLHLQLSLENSLSSDADVTVSILTMNNWYNFSLLLCQEDWNITDFLLLTENNSKFHLESIINITANLSSTKDLLSFLQVQLENIRNSTPTMVMFGCDMGSIRQIFEMSTQFGLSPPDLHWVLGDSQNVEELRTEGLPLGLIAHGKTTQSVFEYYVQDAMELVARAVATATMIQPELALLPSTMNCMDVKTTNLTSGQYLSRFLANTTFRGLSGSIKVKGSTIVSSENNFFIWNLQYDPMGKPMWTRLGSWQGGRIVMDSGIWPEQAQRHKTHFHHPNKLHLRVVTLIEHPFVFTREVDDEGLCPAGQLCLDPMTNDSSILDSLFSSLHSSNDTVPIKFKKCCYGYCIDLLEQLAEDMNFDFDLYIVGDGKYGAWKNGHWTGLVGDLLSGTANMAVTSFSINTARSQVIDFTSPFFSTSLGILVRTRDTAAPIGAFMWPLHWTMWLGIFVALHITAIFLTLYEWKSPFGMTPKGRNRNKVFSFSSALNVCYALLFGRTAAIKPPKCWTGRFLMNLWAIFCMFCLSTYTANLAAVMVGEKIYEELSGIHDPKLHHPSQGFRFGTVRESSAEDYVRQSFPEMHEYMRRYNVPATPDGVQYLKNDPEKLDAFIMDKALLDYEVSIDADCKLLTVGKPFAIEGYGIGLPPNSPLTSNISELISQYKSHGFMDVLHDKWYKVVPCGKRSFAVTETLQMGIKHFSGLFVLLCIGFGLSILTTIGEHIVYRLLLPRIKNKSKLQYWLHTSQRFHRALNTSFVEEKQPCSKTKRVEKRSNMGPQQLMVWNTSNLSHDNQRKYIFNDEEGQNQLGTQTHQDIPLPPRRRELPASLTTNGKADSLNVARNSVMQELSELEKQIQVIRQELQLAVSRKTELEEYQRTNRTCES

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV001292 Mouse Grin3a Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.